Free cancer support
Stomach cancer
Gastric cancer is a malignant tumor originating from the stomach lining and is one of the common gastrointestinal cancers worldwide, with particularly high incidence in Asia. Early-stage gastric cancer often has no obvious symptoms, so it is frequently diagnosed at a middle or advanced stage, increasing the complexity of care. Common types include adenocarcinoma (most common), mucinous carcinoma, and signet-ring cell carcinoma.
High-Risk Factors Include:
Helicobacter pylori infection: Long-term infection is associated with chronic gastritis and gastric ulcers
Dietary habits: Excessive intake of high-salt or pickled foods, low consumption of fruits and vegetables
Family history: Higher risk if there is a family history of gastric cancer
Age factor: Risk increases in individuals over 50 years old
Lifestyle factors: Smoking, excessive alcohol consumption, obesity
Early-stage gastric cancer often shows no obvious symptoms. As the disease progresses, the following may appear:
Indigestion: Loss of appetite, bloating, nausea, early satiety
Upper abdominal pain or discomfort: Often located in the upper abdomen or stomach area
Weight loss and fatigue: Unexplained weight loss and general tiredness
Black or bloody stools: May indicate gastric bleeding
Difficulty swallowing: If the tumor is near the pylorus or gastroesophageal junction
Advanced symptoms: Ascites, abdominal masses, jaundice, or signs of metastasis
Since these symptoms are similar to chronic gastritis, peptic ulcers, and other digestive conditions, early screening is especially important for high-risk individuals.
The diagnosis of gastric cancer relies on multiple examination methods:
Endoscopic Examination (Gastroscopy)
Allows direct visualization of gastric mucosal lesions and tissue biopsy
Confirms tumor type, grade, and stage
Imaging Studies
CT / MRI: Assess tumor size, location, and involvement of surrounding organs
PET-CT: Evaluate possible distant metastasis
Blood Tests
Tumor markers (e.g., CEA, CA72-4) can assist in diagnosis and monitoring disease progression
Molecular and Genetic Testing
Analyzes tumor gene variations to guide personalized care and supportive strategies
The management of gastric cancer can include surgery, radiotherapy/chemotherapy, targeted/immunological support, and personalized care, aiming to slow disease progression and improve quality of life:
Surgery
Early-stage patients may undergo partial or total gastrectomy
Postoperative care combined with nutritional support promotes recovery
Radiotherapy and Chemotherapy
Controls tumor growth and reduces the risk of recurrence
Integrating care plans can help minimize side effects and maintain physical function
Targeted and Immunological Support
Personalized care plans are based on molecular testing results
Nutritional support and immune-enhancing therapies can boost the body’s resistance
Nutritional and Supportive Therapies
High-dose vitamin C, amino acids, glutathione, and trace element infusions
Improve energy levels, support immune function, and maintain overall health
Personalized Monitoring and Care
Regular imaging and blood tests to monitor disease progression
Adjust care plans, nutrition, lifestyle, and psychological support accordingly
High-risk individuals may receive specialized care plans, such as long-term support for chronic gastritis or gastric ulcers
